Understanding how childhood tumors and birth conditions start
Part of Cancer, Genetic & congenital clinical trials.
This study looks at leftover tissue samples from children who have had tumors or birth conditions. Researchers want to learn more about how these conditions develop, and you may help if you or a relative fits the criteria.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You or a close family member has a childhood tumor or a condition you were born with (congenital disease).
- There is a sample of leftover tissue from a previous medical procedure that is no longer needed for your care.
- If the participant is a child, their parent or guardian must agree, and the child also needs to say yes.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study collects a child’s tumor tissue and cells after death to help researchers learn more about cancers and other tumor conditions. You can take part if the required consent and permission are completed.
This study collects and studies tissue or bone marrow samples from certain childhood tumors. The goal is to learn what’s going on inside the cancer (using molecular testing) to better understand the disease and how it may respond to treatment.
This study collects children’s normal and tumor tissue (or blood-related normal samples) and reads their DNA/RNA to look at genetic information. It may help researchers understand cancer-related changes and improve future testing, even when the goal isn’t to treat you directly.
This study collects and stores tumor and blood samples from children and young adults with cancer, blood disorders, or immune conditions. The samples are used to better understand these diseases and could help future treatments.
This study collects tumor (or related) samples to analyze their genes and build a shared research “biobank.” It may help researchers understand cancers better for future diagnosis and treatments.
This study follows people (and sometimes family members) connected to rare solid tumors and collects health information and samples (biospecimens). It helps researchers understand how these cancers develop and builds resources for future research, which may benefit you by contributing to better tailored care for rare cancers.
Hear when a new Congenital Disorders trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.